C
Curis D
D
CRIS
2.45000
USD
-0.33
(-11.87%)
مغلق
حجم التداول
526
الربح لكل سهم
-5
العائد الربحي
-
P/E
-0
حجم السوق
25,632,513
الأخبار المقالات
العنوان: Curis
القطاع: Healthcare
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.